1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Comparison of patient characteristics in those with good-versus-poor outcomes
mRS (0–2) (n = 23) mRS (3–6) (n = 32) P Value Alive (n = 43) Dead (n = 12) P Value ASPECTS (>7) (n = 21) ASPECTS (≤7) (n = 39) P Value Age (median) (yr) 69 (41–85) 73.5 (54–88) .014 69 (41–85) 79 (66–88) .005 72 (52–83) 73 (41–88) .877 Female (%) 26 56.2 .026 37.2 66.6 .101 33.3 51.2 .277 Hypertension (%) 52.1 62.5 .444 60.4 50 .516 56.4 61.9 .786 Diabetes mellitus (%) 26 28.1 .867 23.2 41.6 .205 33.3 25.6 .560 Hyperlipidemia (%) 60.8 46.8 .305 48.8 66.6 .274 61.9 51.2 .587 Current or past smoker (%) 26 9.3 .143 20.9 0 .181 14.2 20.5 .731 Atrial fibrillation (%) 34.3 34.7 .975 32.5 41.7 .733 42.8 35.8 .781 Baseline NIHSS (median) 13 (6–20) 19 (6–27) .001 15 (6–27) 21 (15–26) .001 12 (3–24) 18 (6–27) .003 OTT (median) (min) 120 (61–255) 140 (75–265) .366 140 (61–265) 124 (77–200) .683 137 (61–250) 140 (76–265) .364 IV-tPA (%) 60.9 71.9 .561 67.4 66.7 1.000 69.2 66.7 1.000 IA-tPA/UK (%) 13 6.2 .639 7.3 16.7 .298 11.7 8.3 1.000 Clot retrieval (%) 26.1 21.9 .717 25.5 16.7 .709 23.1 23.8 1.000 rFTD (median) (sec) 3.5 (0–7.5) 5.75 (0–10) .001 4 (0–17) 6.5 (3–20) .002 3.5 (0–6.5) 5.5 (2–20) .002
Note:—IA indicates intra-arterial; rFTD, relative filling delay time; UK, urokinase; OTT, onset to treatment time.